Underutilization of @entity117 for XXXX in the @entity341 .

@entity1 @entity1187 @entity662 @entity566 @entity341 @entity117 @entity1459 @entity583 @entity1281 @entity360
OBJECTIVE: @entity117 ( @entity1281 ) is a simple and cost-effective treatment for @entity1187 ( @entity1187 ). Our objectives were to determine the frequency of @entity1281 administration in the @entity341 ( @entity341 ) for @entity1 with @entity583 or @entity1459 , and to identify @entity1 characteristics associated with its administration. METHODS: This is a retrospective chart review of @entity1 discharged with a final diagnosis of @entity1187 . Data on age, gender, mode of presentation, presence of @entity662 at triage, administration of @entity1281 or not in the @entity341 , dosage and form of @entity1281 received, timing of administration, presence of contraindications to @entity1281 and use of regular @entity1281 prior to @entity341 presentation were recorded. RESULTS: Six hundred and one charts were analyzed. Five hundred and fifty @entity1 (91.5%) received @entity1281 . Only 444 (73.9%) of these 550 @entity1 were administered the @entity1281 appropriately, according to the American Heart Association / American College of Cardiology (AHA/ACC) guidelines. Univariate analysis showed that chart notes "Transport by ambulance," " @entity566 to @entity1281 " and " @entity360 " were associated with a lower probability of the @entity1 being administered @entity1281 . If a @entity1 was noted as taking @entity1281 regularly, it increased the chance of this @entity1 being administered @entity1281 in the @entity341 . CONCLUSION: Although the study @entity341 performed well, administering @entity1281 to 91.5% of @entity1 with @entity1187 , only 73.9% of the @entity1 who received @entity1281 were administered the @entity1281 appropriately, as recommended in the AHA/ACC guidelines. Educational strategies and system changes are necessary to increase the proportion of eligible @entity1187 @entity1 who receive appropriate @entity1281 therapy.
